By Neal Bhatia, MD Chief Medical Editor
Document your practice systems to enhance the patient experience.
By Barbara Sifford
Staying on top of social media trends allows physicians to maintain a marketing edge.
By Naren Arulrajah With Vikas Vij
By Michael Sherling, MD, MBA
Resident Resource Center
Can Google Help with Difficult-to-Determine Etiology?
By Ron Ramirz, JD MS4 and Kathryn Zeoli, MD, FAAD
Native American Health Service Resident Rotation Program
Diagnosis and Managment of Pruritus
By Timothy Berger, MD
Although prescription rates lag, biologic agents may hold the key to sustaining the specialty.
By Alan Menter, MD
An expert panel of dermatologists gathered at the Maui Derm for Dermatologists 2015 meeting to discuss everything from new therapies and comorbidities to genetic issues related to psoriasis.
By Peter Beisser, Contributing Editor
Real-Life Treatment Strategies: Topical Combination Therapy for Plaque Psoriasis in Patients With Skin of Color
Management of psoriasis among individuals with skin of color will become increasingly important for medical professionals. Here’s a review of the distinguishing features of psoriasis in patients with skin of color and their treatment needs.
By Fran E. Cook-Bolden, MD, FAAD
Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigation of agents on the clinical trial circuit. In this entry, we spoke to Ajay Nirula, MD, PhD, Executive Director, Inflammation Development at Amgen about the company’s IL-17 agent brodalumab.
By Ajay Nirula, MD, PhD
When selecting equipment for your practice, considering the demands of your patient population and keeping consistent with your business model are key.
By Sabrina Fabi, MD
An update on topical management options and adjuvant interventions for this common condition.
By Andrew C. Krakowski, MD and Lauren Bennett, PA-C, MMSc
New products and pharmacologic developments